Breast Cancer Screening Tests Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

Breast cancer, a potentially life-threatening condition, can be detected early through screening tests, offering a higher chance of recovery. While breast cancer screening doesn't prevent the disease, it plays a crucial role in identifying signs and symptoms. Typically, breast cancer can be visualized through x-rays or felt as a lump and can manifest as either benign or metastatic. Screening tests for breast cancer are particularly recommended for women aged between 50-70 years, as they are more susceptible to the disease.

Market Dynamics

The Breast Cancer Screening Tests Market is witnessing significant growth driven by several key factors. Patient awareness about healthcare concerns, ongoing research for cancer detection, and prevention efforts are key drivers of this market. Additionally, government initiatives and public awareness campaigns contribute to the market's expansion.

However, the market faces challenges, as patients undergoing biopsies incur significant costs for early detection. MRI scans, although accurate, are time-consuming and expensive.

Regional Outlook

Geographically, the Breast Cancer Screening Tests Market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Currently, North America leads the market, followed by Europe. Factors driving growth in North America include stringent regulatory oversight by organizations like the World Health Organization (WHO) for health and safety concerns and pressure on healthcare institutions to reduce breast cancer-related deaths through early detection.

Europe is also expected to exhibit steady growth in the Breast Cancer Screening Tests Market. Asia-Pacific has emerged as a major player, driven by government and non-government organizations' initiatives, increasing healthcare concerns, and improvements in the healthcare landscape. The market is poised to evolve rapidly across regions.

Key Players

The Breast Cancer Screening Tests Market boasts a multitude of experienced players in the segment. Major players include GE Healthcare, Hologic Inc., Siemens Healthcare GmbH, Allengers Infotech, Carestream Health, Philips Healthcare, Shimadzu Corporation, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Esaote, Agilent Technologies, Hitachi Medical Corporation (HMC), and many others.

Breast Cancer Screening Tests Market: Segmentation

Various Tests

Physical Exam
Laboratory Tests
Imaging Tests

Mammogram or X-Ray

Breast Magnetic Resonance Imaging (MRI)

Genetic Tests

End Users

Research Labs
Cancer Institutes
Diagnostic Centers
Others

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

1. Executive Summary

1.1. Global Breast Cancer Screening Tests Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Breast Cancer Screening Tests Market Outlook, 2018 - 2031

3.1. Global Breast Cancer Screening Tests Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Physical Exam
  - 3.1.1.2. Laboratory Tests
  - 3.1.1.3. Imaging Tests
    - 3.1.1.3.1. Mammogram or X-Ray
    - 3.1.1.3.2. Breast Magnetic Resonance Imaging (MRI)
  - 3.1.1.4. Genetic Tests
3.2. Global Breast Cancer Screening Tests Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Research Labs
  - 3.2.1.2. Cancer Institutes
  - 3.2.1.3. Diagnostic Centres
  - 3.2.1.4. Others
3.3. Global Breast Cancer Screening Tests Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Breast Cancer Screening Tests Market Outlook, 2018 - 2031

4.1. North America Breast Cancer Screening Tests Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Physical Exam
  - 4.1.1.2. Laboratory Tests
  - 4.1.1.3. Imaging Tests
    - 4.1.1.3.1. Mammogram or X-Ray
    - 4.1.1.3.2. Breast Magnetic Resonance Imaging (MRI)
  - 4.1.1.4. Genetic Tests
4.2. North America Breast Cancer Screening Tests Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Research Labs
  - 4.2.1.2. Cancer Institutes
  - 4.2.1.3. Diagnostic Centres
  - 4.2.1.4. Others
- 4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Breast Cancer Screening Tests Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Breast Cancer Screening Tests Market Outlook, 2018 - 2031

5.1. Europe Breast Cancer Screening Tests Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Physical Exam
  - 5.1.1.2. Laboratory Tests
  - 5.1.1.3. Imaging Tests
    - 5.1.1.3.1. Mammogram or X-Ray
    - 5.1.1.3.2. Breast Magnetic Resonance Imaging (MRI)
  - 5.1.1.4. Genetic Tests
5.2. Europe Breast Cancer Screening Tests Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Research Labs
  - 5.2.1.2. Cancer Institutes
  - 5.2.1.3. Diagnostic Centres
  - 5.2.1.4. Others
- 5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Breast Cancer Screening Tests Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.6. France Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkey Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkey Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Breast Cancer Screening Tests Market Outlook, 2018 - 2031

6.1. Asia Pacific Breast Cancer Screening Tests Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Physical Exam
  - 6.1.1.2. Laboratory Tests
  - 6.1.1.3. Imaging Tests
    - 6.1.1.3.1. Mammogram or X-Ray
    - 6.1.1.3.2. Breast Magnetic Resonance Imaging (MRI)
  - 6.1.1.4. Genetic Tests
6.2. Asia Pacific Breast Cancer Screening Tests Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Research Labs
  - 6.2.1.2. Cancer Institutes
  - 6.2.1.3. Diagnostic Centres
- 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Breast Cancer Screening Tests Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.2. China Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.8. India Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Breast Cancer Screening Tests Market Outlook, 2018 - 2031

7.1. Latin America Breast Cancer Screening Tests Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Physical Exam
  - 7.1.1.2. Laboratory Tests
  - 7.1.1.3. Imaging Tests
    - 7.1.1.3.1. Mammogram or X-Ray
    - 7.1.1.3.2. Breast Magnetic Resonance Imaging (MRI)
  - 7.1.1.4. Genetic Tests
7.2. Latin America Breast Cancer Screening Tests Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Breast Cancer Screening Tests Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Breast Cancer Screening Tests Market Outlook, 2018 - 2031

8.1. Middle East & Africa Breast Cancer Screening Tests Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Physical Exam
  - 8.1.1.2. Laboratory Tests
  - 8.1.1.3. Imaging Tests
    - 8.1.1.3.1. Mammogram or X-Ray
    - 8.1.1.3.2. Breast Magnetic Resonance Imaging (MRI)
  - 8.1.1.4. Genetic Tests
8.2. Middle East & Africa Breast Cancer Screening Tests Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Research Labs
  - 8.2.1.2. Cancer Institutes
  - 8.2.1.3. Diagnostic Centres
  - 8.2.1.4. Others
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Breast Cancer Screening Tests Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa Breast Cancer Screening Tests Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa Breast Cancer Screening Tests Market by End User, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Manufacturer vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. GE Healthcare
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Hologic Inc.
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Siemens Healthcare GmbH
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Allengers Infotech,
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Carestream Health.
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Philips Healthcare
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Shimadzu Corporation
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Toshiba Medical Systems Corporation
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Hitachi Medical Corporation
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Esaote
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development
- 9.4.11. Agilent Technologies
  - 9.4.11.1. Company Overview
  - 9.4.11.2. Product Portfolio
  - 9.4.11.3. Financial Overview
  - 9.4.11.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations